Prognostic value of residual cancer burden after neoadjuvant taxane-anthracycline chemotherapy in phenotypic subsets of breast cancer

被引:0
|
作者
Hubbard, R.
Peintinger, F.
Liedtke, C.
Hatzis, C.
Kuerer, H. M.
Valero, V.
Buzdar, A. U.
Hortobagyi, G. N.
Pusztai, L.
Symmans, W. F.
机构
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
[2] Gen Hosp Loeben, Leoben, Austria
[3] Nuvera Biosci Inc, Woburn, MA USA
关键词
D O I
10.1200/jco.2008.26.15_suppl.544
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
544
引用
收藏
页数:1
相关论文
共 50 条
  • [21] Residual cancer burden and neoangiogenesis after neoadjuvant chemotherapy in triple-negative breast cancer
    Miyashita, M.
    Sasano, H.
    Tamaki, K.
    Hirakawa, H.
    Ishida, T.
    Ohuchi, N.
    BREAST, 2017, 32 : S100 - S101
  • [22] Validation of Residual Cancer Burden as Prognostic Factor for Breast Cancer Patients After Neoadjuvant Therapy
    Mueller, Hannah Deborah
    Posch, Florian
    Suppan, Christoph
    Bargfrieder, Ute
    Gumpoldsberger, Melanie
    Hammer, Robert
    Hauser, Hubert
    Dandachi, Nadia
    Prein, Kurt
    Stoeger, Herbert
    Lax, Sigurd
    Balic, Marija
    ANNALS OF SURGICAL ONCOLOGY, 2019, 26 (13) : 4274 - 4283
  • [23] Validation of Residual Cancer Burden as Prognostic Factor for Breast Cancer Patients After Neoadjuvant Therapy
    Hannah Deborah Müller
    Florian Posch
    Christoph Suppan
    Ute Bargfrieder
    Melanie Gumpoldsberger
    Robert Hammer
    Hubert Hauser
    Nadia Dandachi
    Kurt Prein
    Herbert Stoeger
    Sigurd Lax
    Marija Balic
    Annals of Surgical Oncology, 2019, 26 : 4274 - 4283
  • [24] Addition of platinum to sequential taxane-anthracycline neoadjuvant chemotherapy in patients with triple-negative breast cancer: A phase III randomized controlled trial
    Gupta, Sudeep
    Nair, Nita S.
    Hawaldar, Rohini
    Vanmali, Vaibhav
    Parmar, Vani
    Gulia, Seema
    Ghosh, Jaya
    Joshi, Shalaka
    Sarin, Rajiv
    Wadasadawala, Tabassum
    Panhale, Tejal
    Desai, Sangeeta
    Shet, Tanuja
    Patil, Asawari
    Chitkara, Garvit
    Rath, Sushmita
    Bajpai, Jyoti
    Thakkur, Meenakshi
    Badwe, Rajendra
    CANCER RESEARCH, 2023, 83 (05)
  • [25] Taxane and Anthracycline Based Neoadjuvant Chemotherapy for Locally Advanced Breast Cancer : Institutional Experience
    Gogia, Ajay
    Raina, Vinod
    Deo, Suryanarayan Vishnu
    Shukla, Nootan Kumar
    Mohanti, Bidhu Kalyan
    Sharma, Daya Nand
    ASIAN PACIFIC JOURNAL OF CANCER PREVENTION, 2014, 15 (05) : 1989 - 1992
  • [26] Prognostic value of the Residual Cancer Burden index according to breast cancer subtype: Validation on a cohort of BC patients treated by neoadjuvant chemotherapy
    Hamy, Anne-Sophie
    Darrigues, Lauren
    Laas, Enora
    De Croze, Diane
    Topciu, Lucian
    Lam, Giang-Thanh
    Evrevin, Clemence
    Rozette, Sonia
    Laot, Lucie
    Lerebours, Florence
    Pierga, Jean-Yves
    Osdoit, Marie
    Faron, Matthieu
    Feron, Jean-Guillaume
    Lae, Marick
    Reyal, Fabien
    PLOS ONE, 2020, 15 (06):
  • [27] Effects of taxane-anthracycline and taxane only treatment on cardiac function in breast cancer—a retrospective cohort study
    Árpád Kézdi
    Emese Szelke
    Magdolna Dank
    Dorottya Mühl
    Gyöngyvér Szentmártoni
    Gergely Szabó
    Dominic Joseph Fogarasi
    István Takács
    Viktor J Horváth
    Ádám G Tabák
    Cardio-Oncology, 11 (1)
  • [28] Late pancreatie toxielty in patients with breast cancer after taxane-anthracycline-based neoadjuvant and adjuvant chemotherapy
    Kopp, M. V.
    Koroleva, I.
    Kasulin, A. N.
    Kucheryavyy, J. A.
    Byakhov, M. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [29] Prognostic value of subtype changes after neoadjuvant chemotherapy in primary breast cancer
    Matsumoto, Akiko
    Umemoto, Yasuko
    Yoshikawa, Mio
    Jinno, Hiromitsu
    ANNALS OF ONCOLOGY, 2018, 29
  • [30] Prognostic Value of Receptor Change After Neoadjuvant Chemotherapy in Breast Cancer Patients
    Ozdemir, Ozlem
    Zengel, Baha
    Cavdar, Demet Kocatepe
    Yilmaz, Cengiz
    Durusoy, Raika
    EUROPEAN JOURNAL OF BREAST HEALTH, 2022, 18 (02) : 167 - 171